VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
VintaBio has raised $64.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2023.
VintaBio's investors include Decheng Capital.
VintaBio is headquartered in Philadelphia, United States.
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
VintaBio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VintaBio — Funding & Investors." VCBacked, April 11, 2023, https://www.vcbacked.co/company/vintabio. Accessed August 15, 2026.
VCBacked. (2023). VintaBio — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/vintabio
{{cite web |title=VintaBio — Funding & Investors |url=https://www.vcbacked.co/company/vintabio |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated